Latin America Dermatological Therapeutics Market 2019-2028

2.1. Market Definition
2.2. Key Insights
2.2.1. Advancements in Biologics
2.2.2. Atopic Dermatitis is Anticipated to Grow at Highest CAGR
2.3. Porter's Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Impact of COVID-19 – Dermatological Therapeutics
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Market Drivers
2.7.1. Increasing Burden of Dermatological Diseases
2.8. Market Restraints
2.8.1. Grave Side-Effects for Certain Classes of Therapeutic Drugs
2.9. Market Opportunities
2.9.1. Rise in Awareness Levels of Disease Origin and Progression
2.10. Market Challenges
2.10.1. Unawareness Towards Dermatological Diagnosis

3.1. Anti-Infectives
3.2. Corticosteroids
3.3. Anti-Acne
3.4. Calcineurin Inhibitors
3.5. Retinoids
3.6. Other Drug Classes

4.1. Alopecia
4.2. Herpes
4.3. Psoriasis
4.4. Rosacea
4.5. Atopic Dermatitis
4.6. Acne Vulgaris
4.7. Other Applications

5.1. Latin America
5.1.1. Country Analysis
5.1.2. Brazil
5.1.3. Mexico
5.1.4. Rest of Latin America

6.1. Abbvie Inc
6.2. Allergan
6.3. Almirall
6.4. Amgen Inc
6.5. Bausch Health Companies Inc
6.6. Galderma
6.7. GlaxoSmithKline plc
6.8. Johnson & Johnson
6.9. Novartis Ag
6.10. Pfizer Inc
6.11. AGI Dermatics
6.12. Leo Pharma A/S
6.13. Merck & Co

7.1. Research Scope & Deliverables
7.2. Sources of Data
7.3. Research Methodology

Table 1: Latin America Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Latin America Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 5: Latin America Dermatological Therapeutics Market, by Drug Class, 2019-2028 (In $ Billion)
Table 6: Latin America Dermatological Therapeutics Market, by Application, 2019-2028 (In $ Billion)

Figure 1: Porter's Five Forces Analysis
Figure 2: Latin America Dermatological Therapeutics Market, by Anti-Infectives, 2019-2028 (In $ Billion)
Figure 3: Latin America Dermatological Therapeutics Market, by Corticosteroids, 2019-2028 (In $ Billion)
Figure 4: Latin America Dermatological Therapeutics Market, by Anti-Acne, 2019-2028 (In $ Billion)
Figure 5: Latin America Dermatological Therapeutics Market, by Calcineurin Inhibitors, 2019-2028 (In $ Billion)
Figure 6: Latin America Dermatological Therapeutics Market, by Retinoids, 2019-2028 (In $ Billion)
Figure 7: Latin America Dermatological Therapeutics Market, by Other Drug Classes, 2019-2028 (In $ Billion)
Figure 8: Latin America Dermatological Therapeutics Market, by Alopecia, 2019-2028 (In $ Billion)
Figure 9: Latin America Dermatological Therapeutics Market, by Herpes, 2019-2028 (In $ Billion)
Figure 10: Latin America Dermatological Therapeutics Market, by Psoriasis, 2019-2028 (In $ Billion)
Figure 11: Latin America Dermatological Therapeutics Market, by Rosacea, 2019-2028 (In $ Billion)
Figure 12: Latin America Dermatological Therapeutics Market, by Atopic Dermatitis, 2019-2028 (In $ Billion)
Figure 13: Latin America Dermatological Therapeutics Market, by Acne Vulgaris, 2019-2028 (In $ Billion)
Figure 14: Latin America Dermatological Therapeutics Market, by Other Applications, 2019-2028 (In $ Billion)
Figure 15: Latin America Dermatological Therapeutics Market, Regional Outlook, 2019 & 2028 (In %)
Figure 16: Brazil Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 17: Mexico Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 18: Rest of Latin America Dermatological Therapeutics Market 2019-2028 (In $ Billion)